BhandariYSSarkariNBS. Subdural empyema. A review of 37 cases. J Neurosurg1970; 32: 35–9.
2.
CoonrodJDDansPE. Subdural empyema. Am J Med1972; 53: 85–91.
3.
KaufmanDMMillerMHSteigbigelNH. Subdural empyema: Analysis of 17 recent cases and reviews of the literature. Medicine1975; 56: 485–98.
4.
GlasauerFECootsDLevyLF. Subdural empyema in Africans in Rhodesia. Neurosurgery1978; 3: 385–91.
5.
FergusonLGotoffSP. Subdural empyema in an infant due to group B beta-hemolytic Streptococcus. Am J Dis Child1977; 131: 97.
6.
WeinnanDSamarasingheHHR. Subdural empyema. Aust NZ J Surg1972; 41: 346–30.
7.
HitchcockEAndreasA. Subdural empyema: A review of 29 cases. J Neurosurg Psych1964; 27: 422.
8.
FarmerTWWiseGR. Subdural empyema in infants, children, and adults. Neurology1973; 23: 256–61.
9.
RubenfireMGassHHGoldsteinPS. Gentamicin therapy of paracolobactrum epidural abscess and meningitis. Am J Med Sci1969; 257: 191.
10.
WeinsteinRJYoungLSHewittWL. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and. J Lab Clin Med1975; 86: 853.
11.
JonesRNFuchsPCSommersHM. Moxalactam LY 127935: A new semisynthetic 1-oxa-β-lactam antibiotic with remarkable antimicrobial activity: In vitro comparison with cefamandole and tobramycin. Antimicrob Agents Chemother1980; 17: 750.
12.
OlsonDAHoeprichPDNolanSM. Successful treatment of gram-negative bacillary meningitis with moxalactam. Ann Intern Med1981; 95: 302.
13.
PreheimLCPennRGSandersCC. Emergence of resistance to moxalactam and aminoglycosides with moxalactam therapy of Pseudomonas infections. 21st Interscience Conference on Antimicrobial Agents and Chemotherapy, Nov 4–6, 1981, Chicago (abstract 729).